Gout researchers not using OMERACT


Gout researchers are not using OMERACT recommended trial outcomes. Acute gout trials reported an average of 2.9 out of the 5 proposed OMERACT outcome domains, while 2.5 of the 9 preliminary domains were included in chronic gout trials. Research also showed a preference for non-patient reported outcomes. To truly understand burden of disease and treatment ...


Already a member? Login to keep reading


OR
© 2017 the limbic